共 196 条
- [11] Norris EV(2008)Alendronate for fracture prevention in postmenopause Am Fam Physician. 78 579-2034
- [12] Clark EM(2013)EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases Ann Rheum Dis. 72 1905-2187
- [13] Mazor M(2017)Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting Osteoporos Int 28 2023-1928
- [14] Velten S(2015)Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996-2012: An Ecological Analysis J Bone Miner Res. 30 2179-9
- [15] Andrade E(2014)The osteoporosis treatment gap J Bone 29 1926-983
- [16] Yood A(2019)The impact of hip fracture on health-related quality of life and activities of daily living: the SPARE-HIP prospective cohort study Arch Osteoporos 14 56-1397
- [17] Nielsen D(2017)Prevención Primaria y secundaria de la fractura de cadera por fragilidad ósea en la población del sector sanitario Rev Esp Salud Publica. 91 1-65
- [18] Huniche L(1984)Consensus methods - characteristics and guidelines for use Am J Public Health. 74 979-669
- [19] Brixen K(2018)A global call to action to improve the care of people with fragility fractures Injury 49 1393-303
- [20] Sahota O(2011)Referral and consultation communication between primary care and specialist physicians: finding common ground Arch Intern Med. 171 56-1529